Evidence map›Paper›PMID 17702866›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation.

Thierry Passeron, Julio C Valencia, Corine Bertolotto, Toshihiko Hoashi, Elodie Le Pape, Kaoruko Takahashi, Robert Ballotti, Vincent J Hearing

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. 3,4,5-Tri-Frontiers in cell and developmental biology · 2020
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Thierry PasseronPigment Cell Biology Section, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Julio C Valencia
Corine Bertolotto
Toshihiko Hoashi
Elodie Le Pape
Kaoruko Takahashi
Robert Ballotti
Vincent J Hearing
National Institutes of Health · USNational Cancer Institute · USUniversité Côte d'Azur · FR

Funding

The Regulation of Mammalian PigmentationZIABC010786 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEARING, VINCENT J · 2009 to 2014
$2.2M
The Regulation of Mammalian PigmentationZ01BC010786 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEARING, VINCENT J · 2007 to 2008
$842k
Intramural NIH HHS
6 · The paper itself

Abstract

SOX (SRY type HMG box) proteins are transcription factors that are predominantly known for their roles during development. During melanocyte development from the neural crest, SOX10 regulates microphthalmia-associated transcription factor, which controls a set of genes critical for pigment cell development and pigmentation, including dopachrome tautomerase and tyrosinase. We report here that another SOX factor, SOX9, is expressed by melanocytes in neonatal and adult human skin and is up-regulated by UVB exposure. We demonstrate that this regulation is mediated by cAMP and protein kinase. We also show that agouti signal protein, a secreted factor known to decrease pigmentation, down-regulates SOX9 expression. In adult and neonatal melanocytes, SOX9 regulates microphthalmia-associated transcription factor, dopachrome tautomerase, and tyrosinase promoters, leading to an increase in the expression of these key melanogenic proteins and finally to a stimulation of pigmentation. SOX9 completes the complex and tightly regulated process leading to the production of melanin by acting at a very upstream level. This role of SOX9 in pigmentation emphasizes the poorly understood impact of SOX proteins in adult tissues.

Indexed as

Cell DifferentiationCyclic AMPGene Expression RegulationHigh Mobility Group ProteinsHumansIn Situ HybridizationMelanocytesProtein KinasesReverse Transcriptase Polymerase Chain ReactionSkin PigmentationSOX9 Transcription FactorTranscription FactorsUltraviolet RaysCyclic AMPHigh Mobility Group ProteinsProtein KinasesSOX9 protein, humanSOX9 Transcription FactorTranscription Factors

Identifiers

PMID17702866
PMCPMC1955778
OpenAlexW2052156954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.